Lucas Blanchard
Toulouse, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Targeting Myeloid Cells for Cancer Immunotherapy.
Journal: Cancer immunology research
Published: April 01, 2025
Fc-optimized CD40 agonistic antibody elicits tertiary lymphoid structure formation and systemic antitumor immunity in metastatic cancer.
Journal: Cancer cell
Published: October 10, 2024
Fc-optimized anti-CTLA-4 antibodies increase tumor-associated high endothelial venules and sensitize refractory tumors to PD-1 blockade.
Journal: Cell reports. Medicine
Published: July 30, 2024
A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancers.
Journal: Science (New York, N.Y.)
Published: June 08, 2023
FcγRIIB Is an Immune Checkpoint Limiting the Activity of Treg-Targeting Antibodies in the Tumor Microenvironment.
Journal: Cancer immunology research
Published: May 21, 2023
Tumor-associated HEVs mediate lymphocyte entry into tumors during cancer immunotherapy
Journal: Medecine sciences : M/S
Published: September 12, 2022
Tumor-associated high endothelial venules mediate lymphocyte entry into tumors and predict response to PD-1 plus CTLA-4 combination immunotherapy.
Journal: Cancer cell
Published: April 09, 2021
High endothelial venules (HEVs) in immunity, inflammation and cancer.
Journal: Angiogenesis
Published: March 29, 2021
Showing 1-10 of 10
Last Updated: 09/26/2026